Additions bolster Vanderbilt-Ingram research team
William Pao, M.D., Ph.D.
William Tansey, Ph.D.
Vanderbilt-Ingram Cancer Center
• William Pao, M.D., Ph.D., has accepted a new post as associate professor of Medicine in the Division of Hematology/Oncology at Vanderbilt-Ingram Cancer Center, with secondary appointments in the Departments of Cancer Biology and Pathology.
He also has been named assistant director of Personalized Cancer Medicine and an Ingram Associate Professor of Cancer Research.
Pao's research focus will include defining clinically relevant molecular subsets of lung cancer.
Pao comes to Vanderbilt-Ingram from Memorial Sloan-Kettering Cancer Center, New York N.Y., where he is an assistant member of the Human Oncology and Pathogenesis Program and assistant attending physician in the Thoracic Oncology Service, Department of Medicine at Memorial Hospital for Cancer and Allied Sciences. He also serves as assistant professor of Medicine, Joan and Sanford I. Weill Medical College of Cornell University, New York Presbyterian Hospital.
Pao graduated magna cum laude from Harvard College and earned his M.D. and Ph.D. from Yale University, New Haven, Conn.
He was a fellow in Medical Oncology at Memorial Sloan-Kettering Cancer Center and a postdoctoral fellow in the Program in Cancer Biology and Genetics at Sloan-Kettering Institute.
He is the recipient of numerous research grants from the National Cancer Institute and other medical research foundations and has authored more than 50 published papers.
• William Tansey, Ph.D., joins VICC as professor of Cell and Developmental Biology and co-leader of the Genome Maintenance Program.
He also has been named an Ingram Professor of Cancer Research. His research will focus on the regulation of gene activity in normal and cancer cells.
Tansey is currently a professor at Cold Spring Harbor Laboratory in New York.
He is a member of the Molecular and Cellular Biology Program and the Genetics Program at State University of New York, Stony Brook.
Tansey graduated from the University of Sydney, Australia, where he earned a Bachelor of Science degree with honors and a doctoral degree. He was a postdoctoral fellow at Cold Spring Harbor Laboratory.
He is the recipient of numerous research grants and has published extensively.
“We are pleased to have these two internationally respected cancer investigators join our research team,” said Jennifer Pietenpol, Ph.D., director of Vanderbilt-Ingram.
“We're in an exciting new age of cancer research and their commitment to discovery and translation will accelerate advances from our Center.”